Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vildan, Tasdemir"'
Autor:
Neyran Kertmen, Vildan Tasdemir, Taner Babacan, Alev Turker, Alma C Aslan, Ayse Kars, Saadettin Kilickap, Ibrahim Barista, Saim Furkan Sarici, Evren Ozdemir
Publikováno v:
International Journal of Hematology and Oncology. 26:88-95
The optimal treatment of non-Hodgkin lymphoma (NHL) in elderly patients is controversial. In this study, we evaluated the outcomes for elderly patients who were treated with combined chemotherapy regimens. Patients with lymphoma aged over 75 treated
Publikováno v:
International Urology and Nephrology. 47:1977-1983
Hyponatremia is a common disorder and hyponatremia in the outpatient setting is not extensively studied. Our aim was to investigate the characteristics of hyponatremia in ambulatory patients. Seventy-six adult outpatients with hyponatremia were enrol
Autor:
Gokmen U, Erdem, Kadri, Altundag, Nuriye Y, Ozdemir, Suleyman, Sahin, Nebi S, Demirci, Fatih, Karatas, Yakup, Bozkaya, Aydin, Aytekin, Vildan, Tasdemir, Alma C, Aslan, Ali R, Sever, Nurullah, Zengin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 22(2)
It is well-known that tumor phenotype may change during the progression of breast cancer (BC). The purpose in this study was to compare the discordance in estrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor receptor
Autor:
Hakan, Buyukhatipoglu, Taner, Babacan, Neyran, Kertmen, Ozan, Balakan, Ali, Suner, Ozturk, Ates, Furkan, Sarici, Alma, Aslan, Omer, Diker, Vildan, Tasdemir, Yavuz, Ozisik, Kadri, Altundag
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20(1)
To compare the effectiveness of adjuvant chemotherapy regimens in triple negative breast cancer (TNBC) for which no protocol has been determined to be treatment of choice.In this single-center retrospective trial, we analyzed the adjuvant regimens of
Publikováno v:
Journal of Clinical Oncology. 34:e21597-e21597
e21597Background: Iron deficiency (ID) and anemia are frequent comorbidities in patients with a variety of cancers. The negative impact of anemia on physical performance and anti-tumor therapy is w...
Autor:
Furkan Sarici, Mustafa Solak, Ozge Keskin, Kadri Altundag, Neyran Kertmen, Buket Ozden, Omer Diker, Sercan Aksoy, Taha Solakoglu, Vildan Tasdemir, Yalin S Sahin, Sevda Aygun
Publikováno v:
Journal of Turgut Ozal Medical Center. 23:192
Autor:
Omer Diker, Vildan Tasdemir, Sercan Aksoy, Neyran Kertmen, Yusuf Karakas, Omer Dizdar, Kadri Altundag, Alma Cenoli, Ozge Keskin, Yavuz Ozisik
Publikováno v:
Web of Science
e12037 Background: Neuroendocrine cancer of the breast is rarely seen and grouped into small cell, large cell and carsinoid like carcinoma variants. In our study demographic features of neuroendocr...